NCT07603674 Precision Based Primary Care for Patients With Musculoskeletal Disorders
| NCT ID | NCT07603674 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Musculoskeletal Disorders (MSDs) |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-04-16 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-04-16 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this research project, the researchers will implement the Start-MSK tool, which is a screening instrument to support and facilitate the work of directing the right treatment to the right patient with musculoskeletal pain to promote recovery and improve health outcomes. The screening tool aims to identify prognostic factors to stratify patients into groups with different risks for long-term pain and disability. A total of 300 patients, 18 years and older, with musculoskeletal pain who seek primary care rehabilitation and a physiotherapist will be recruited. For this project, the investigaters are in contact with 10-15 primary care units in the Stockholm, Västra Götaland, Uppsala and Skåne Regions. Patients who are recruited will receive care from a physiotherapist and with a follow-up for 6 months. The primary aim is to investigate whether Start-MSK can predict the outcome (pain, quality of life) of the treatment at 3 months, and at long-term follow-up 6 months. The investigators will also conduct interview studies using focus groups with the physiotherapists and individual interviews with included patients who are part of the study to capture their experiences of using the Start-MSK; about how the participants feel the use has affected treatment and the measures they have received. Through Start-MSK, which is a step towards precision-based treatment for musculoskeletal pain, some of the long-term pain should be preventable.
Eligibility Criteria
Inclusion Criteria: * adults with musculoskeletal pain (neck, back, shoulder, hip, knee, multisite pain) * recruited from primary care, aged 18 and above Exclusion Criteria: * malignant and inflammatory diseases * inability to understand spoken and written Swedish
Contact & Investigator
Philip von Rosen, Associate professor, PhD
PRINCIPAL INVESTIGATOR
Karolinska Institutet
Frequently Asked Questions
Who can join the NCT07603674 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Musculoskeletal Disorders (MSDs). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07603674 currently recruiting?
Yes, NCT07603674 is actively recruiting participants. Contact the research team at eva.rasmussen.barr@ki.se for enrollment information.
Where is the NCT07603674 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT07603674 clinical trial?
NCT07603674 is sponsored by Karolinska Institutet. The principal investigator is Philip von Rosen, Associate professor, PhD at Karolinska Institutet. The trial plans to enroll 300 participants.